Microbiomics research is progressing at a rapid rate as we get a better understanding of the impact of the microbiome on our bodies via Eagle Genomics
Current and future advancements will have a profound socioeconomic impact globally. Eagle Genomics is actively engaged with global companies in their microbiomic R&D programmes. Our mixed expertise in biology, bioinformatics and knowledge management coupled with our powerful software platform has already transformed new product innovation in the microbiomic sector.
Roger Guillemin identified the molecules in the brain that control the production of hormones in…
In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…
We spoke to John Chave, director-general at trade body Cosmetics Europe, about changing regulations, what’s…